2 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Ropeginterferon: new trials by email Literature Review of Ropeginterferon trials Research Report on Ropeginterferon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ropeg-Interferon in People With Polycythemia Vera Ropeginterferon - Polycythemia Vera (PV), JAK2 Mutation | Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 55 | 2026-10-30 | 2026-10-21 |
| Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis Ropeginterferon - JAK2 Mutation | Phase 1 | Recruiting | Brigham and Women's Hospital | 12 | 2026-07-24 | 2026-07-28 |
| Ropeginterferon for Treatment Free Remission Ropeginterferon - CML (Chronic Myelogenous Leukemia) | Phase 4 | Completed | Dong-Wook Kim | 65 | 2021-11-30 | 2025-08-22 |
| Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis Bosutinib, Ropeginterferon - Chronic Myeloid Leukemia | Phase 2 | Completed | St. Olavs Hospital | 212 | 2019-03-25 | 2025-06-08 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Myeloproliferative Disorders (1) · Polycythemia Vera (1)
Brigham and Women's Hospital (1) · Dong-Wook Kim (1) · Memorial Sloan Kettering Cancer Center (1) · St. Olavs Hospital (1)
United States (2) · Denmark (1) · Finland (1) · Norway (1) · South Korea (1) · Sweden (1)
Chi-Joan How (1) · Henrik Hjorth-Hansen, md phd (1) · Lydia Roy, md phd (1) · Raajit Rampal, MD, PhD (1) · Tom Christian Martinsen, md phd (1)
2018 (1)